As attention moves onto the proposed Single Patient Record, questions are once again being asked of the purpose, value and scope of its older sibling, the £330m Federated Data Platform. Future Health Intelligence’s Jon Hoeksma examines claims made on behalf of FDP.
As attention moves onto the proposed Single Patient Record, questions are again being asked about the purpose, value and scope of its older sibling: the £330m Federated Data Platform.
Reports that one of the largest hospital trusts in England has declined to take FDP modules, saying they would lose functionality they already have, beg further questions about the benefits being claimed for FDP.
In November 2023, Palantir was awarded a controversial deal for FDP, the follow-on project from the NHS Data Store used in the pandemic to track vaccinations and immunisation.
FDP was procured by NHSE England (NHSE) with the stated aim of supporting: elective recovery; care coordination; vaccination and immunisation; population health management; and supply chain management.
Details of claimed benefits from FDP remain limited
Despite being championed by NHS England and expected to feature strongly in the 10-year plan, there is so far little published data and evaluation of benefits, with reported benefits so far largely anecdotal.
However, the limited evidence of benefits or evaluation has so far not appeared to slow down the drumbeat for rapid roll-out.
FDP has already been mandated by NHS England as a standard data analytics platform for use by Integrated Care Boards, upon which a series of common applications can then be delivered. It’s unknown whether the FDP contract has any provision for Palantir to be paid less as the number of ICBs is halved.
All trusts have been told to plan to use FDP by Summer 2026
And although it has not yet been mandated for trusts, it is being strongly pushed by the senior leadership of NHSE. In August 2024 NHSE director of transformation Vin Diwakar wrote to all trusts and ICBs telling them they should prepare plans for how they plan to use FDP within two years.
FDP is now being further advocated by some, including influential consultants McKinsey, as the essential foundation for the planned Single Patient Record.
Roll-out began in 2023 in ICBs as an analytics tool. NHS England has subsequently told ICBs that they should decommission analytical tools other than FDP, which should become their default. This despite caution being urged by Marc Farr, chair of the Chief Analytical Officers Network, that FDP should be shown to deliver benefits before existing analytics tools in use are decommissioned.
FDP trust modules replicate functionality some trusts already have
More controversially, FDP has also moved on to target waiting lists and care co-ordination and discharge planning activity in trusts. In many cases seeking to replicate functionality and well-established tools already in use and provided by Electronic Patient Records and Patient Administration Systems.
While there has been a degree of scepticism of the value of FDP in provider trusts, and questions about what the purpose and ultimate ambition of FDP are, the prevailing attitude from trusts leaders is to try to make the most of the platform.
In December 2023 HSJ reported that five trusts piloting FDP modules disputed NHSE claims that they were ‘actively realising’ benefits.
Leeds declines to take FDP modules, saying they would ‘lose existing functionality’
But in what may prove a highly significant development one high profile trust has firmly pushed back on FDP, declining to replace existing functionality with unproven FDP modules. Professor Phil Wood, the CEO of one of the largest hospital trusts in England has written the NHSE director of transformation Vin Diwakar saying that adopting FDP modules would mean losing current functionality.
According to The Register, the chief executive and chief digital information officer of Leeds Teaching Hospitals Trust – have said the trust would lose functionality if it adopted the FDP for some of its use cases.
The Register quotes a letter from the trusts that says of the FDP Inpatient Care Coordination, Referral to Treatment and Optica (Optimised Patient Tracking and Intelligent Choices) modules, three of the main FDP tools trusts are being told to adopt, “We already have services within the trust that deliver outpatient care coordination, referral-to-treatment validation and discharge planning… From the descriptions we have of these FDP products we believe we would lose functionality rather than gain it by adopting them.”
The report, if confirmed, marks the first known instance of a trust declining to take FDP modules and questioning whether they offer sufficient functionality and benefits.
It also raises questions of whether other trusts have more quietly declined to take FDP modules, preferring to stick to existing proven capabilities.
DHSC says 50% of trusts signed up to use FDP
The Department of Health and Social Care (DHSC) says that of the 215 trusts in England 120 NHS trusts have so far signed up to use the FDP, including 84 percent of hospital trusts.
Of these, 72 are said to be live as part of a phased rollout to provide better care and services for patients.”
According to NHSE figures, 45 of England’s 215 hospital trusts were actively using Palantir’s Federated Data Platform (FDP) by the end of 2024.
NHSE pushing trusts to adopt four modules initially
The most widespread benefits are said to be waiting list and inpatient care co-ordination modules, followed by Referral to Treatment and Optica. Further modules are expected to follow these initial four.
Dorset, South London and North Cumbria are named as sites that have benefited from using FDP modules. But the details on benefits provided on the NHSE website are limited with no independent validation or evaluation.
“This functionality helps clinical teams identify which patient entries no longer need to be included and can be safely removed from the waiting list, ensuring that the correct patients receive the necessary care and attention,” says the NHS website
“This product also aids with theatre scheduling, ensuring that clinicians have the data they need to prioritise patients with the most urgent needs and book slots for surgery.”
Examples of benefits on the NHSE website cite some large numbers without qualifying or backing them up, raising a host of questions.
Care Coordination Module
For the FDP Care Coordination module, the NHSE website states that up to the end of December 2024, FDP resulted in 69,909 ‘additional patients undergoing procedures in theatres’, this figure is described as “a cumulative total of additional patients undergoing procedures in theatres by NHS trusts with the Inpatient Care Coordination Solution until end of December 2024, compared to the previous period without FDP use.”
Superficially, this big number sounds impressive. But is it? No supporting data is provided on whether other factors such as staffing levels, or elective recovery measures may have impacted the increased number of procedures, as they likely will have. The statement strongly applies the difference is all attributable to FDP.
Waiting List Management Module
For the FDP Waiting List Management module the NHSE website claims 207,122 “patients safely requested for removal from the waitlist”. Again, a large number, but what does it mean? How many patients were safely removed? How was the determination made they should be removed? How many would have been removed in a control group not using the FDP waiting list module? And has there been a proper assessment of the impact on patient safety?
Referral to Treatment Module
For the RTT module, described as “Increasing checks that the right actions have been taken along the patient’s care pathway, in line with NHS standards,” the website says 1,107,622 records were reviewed up to the end of December using the RTT product, with 271,838 removed from waiting lists ‘for a variety of reasons’. Again, the claimed benefits raises a host of questions.
Optica module
For the Optica product, possibly the most significant benefits are claimed. “18.8% decrease in average number of delay days for long stay patients after rolling out Optica.” How has this been calculated?
NHSE must publish evidence for FDP benefit claims and commission independent evaluation
In each instance, there is no indication that a rigorous evaluation has yet been carried out or supporting evidence to back claims published. FDP modules may be performing well or capable of delivering significant benefits to the NHS and patients, but the claims are being made so far lack rigour.
The benefits claimed also imply that FDP modules are being implemented into greenfield sites, which is clearly not the case. A more rigorous evaluation would need to take account of what trusts already do and show that FDP modules offer more than trusts have already.
As in the case of Leeds, the FDP modules described closely match capabilities already available in many trusts from existing local systems.
The unfortunate impression left from the NHSE website benefits claims is that the roll-out of FDP is an imperative irrespective of benefits first being shown to be achieved.
McKinsey recommends ‘spirited buy-in’ and forcing ‘FDP-first’ approach
No doubts about FDP from its management consultant supporters though. In a new article championing FDP McKinsey says “As rollout of the NHS Federated Data Platform (FDP) nears completion, it offers a transformative opportunity to improve performance and patient outcomes. Fulfilling this potential will need a coordinated focus on value by the NHS, and spirited buy-in from across the healthcare ecosystem.”
And if a ‘spirited buy-in’ doesn’t do the job McKinsey calls for NHS to be given no choice, “the NHS could also make clear that an ‘FDP-first’ approach is expected, with both explicit guidance and financial incentives for the removal of technical debt and a high bar for digital procurement not aligned to the FDP platform.
NHS England lists the following trusts as all getting benefits from using FDP:
Barts Health NHS Trust
Bolton NHS Foundation Trust
Chelsea and Westminster Hospital NHS Foundation Trust
Chesterfield Royal Hospital NHS Foundation Trust
Countess of Chester Hospital NHS Foundation Trust
Croydon Health Services NHS Trust
Dorset Healthcare University NHS Foundation Trust
East Suffolk and North Essex NHS Foundation Trust
East Sussex Healthcare NHS Trust
Gateshead Health NHS Foundation Trust
Great Western Hospitals NHS Foundation Trust
Hampshire Hospitals NHS Foundation Trust
Harrogate and District NHS Foundation Trust
Imperial College Healthcare NHS Trust
James Paget University Hospitals NHS Foundation Trust
Kettering General Hospital NHS Foundation Trust
Kingston Hospital NHS Foundation Trust
Lewisham and Greenwich NHS Trust
London North West University Healthcare NHS Trust
Medway NHS Foundation Trust
Mid Yorkshire Teaching NHS Trust
North Cumbria Integrated Care NHS Foundation Trust
North Tees and Hartlepool NHS Foundation Trust
Northampton General Hospital NHS Trust
Northumbria Healthcare NHS Foundation Trust
Royal Surrey County Hospital NHS Foundation Trust
Royal United Hospitals Bath NHS Foundation Trust
Salisbury NHS Foundation Trust
South Tees Hospitals NHS Foundation Trust
South Tyneside and Sunderland NHS Foundation Trust
Southport and Ormskirk Hospital NHS Trust
The Hillingdon Hospitals NHS Foundation Trust
The Newcastle Upon Tyne Hospitals NHS Foundation Trust
The Walton Centre NHS Foundation Trust
United Lincolnshire Hospitals NHS Trust
University Hospitals of Derby and Burton NHS Foundation Trust
University Hospitals of Leicester NHS Trust
University Hospitals of North Midlands NHS Trust
West Hertfordshire Teaching Hospitals NHS Trust
York and Scarborough Teaching Hospitals NHS Foundation Trust